Skip to Main Content

Paper Details

Therapeutic targeting of HYPDH/PRODH2 with N-propargylglycine offers a Hyperoxaluria treatment opportunity.
Biochim Biophys Acta Mol Basis Dis
0
2024
4-hydroxyproline, HYPDH, Hyperoxaluria, N-propargylglycine, PH, PRODH2, mouse, primary hyperoxaluria
Author NameAffiliation
Birgit SchillingBuck Institute for Research on Aging
Birgit SchillingBuck Institute for Research on Aging
Christopher C BenzBuck Institute for Research on Aging
Christopher C BenzBuck Institute for Research on Aging
Lisa M EllerbyBuck Institute for Research on Aging
  • 1 - 5

Datasets

Release 1.2